Vernalis

Equities

VER

Biotechnology & Medical Research

Delayed London S.E. Other stock markets			5-day change	1st Jan Change
- ^GBX	-.--%		+0.65%	-29.32%

2017

Vernalis : hit by fresh U.S. setback for cough and cold drug

RE

Rights Issue: 47 new shares @ 0.2 GBP for 16 existing shares

February 09, 2012

MarketScreener.com By

Rights Issue: 47 new shares @ 0.2 GBP for 16 existing shares

© Factset - 2012

Latest news about Vernalis

Vernalis : hit by fresh U.S. setback for cough and cold drug

17-08-07

RE

Chart Vernalis

Duration

Period

Company Profile

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+17.96%	44.96B
IQVIA HOLDINGS INC.	+1.17%	42.65B
LONZA GROUP AG	+48.77%	41.85B
CELLTRION, INC.	-4.27%	29.04B
ICON PUBLIC LIMITED COMPANY	+11.42%	26.08B
ALNYLAM PHARMACEUTICALS, INC.	-21.39%	19.03B
BIO-TECHNE CORPORATION	+4.86%	12.75B
MEDPACE HOLDINGS, INC.	+27.29%	12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.50%	11.75B

Other Biotechnology & Medical Research

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW